Insider · CIK 0001677896

VARKI PAUL

Reports to the SEC for 2 companies · WAYNE, PA

sec.gov

Transactions

Companies

Filings

CIK

0001677896

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-10	AVTXAvalo Therapeutics, Inc.F Tax Payment	Chief Legal Officer	FTax Payment	−1,081 sh	$13.10	−$14.2K	32,576
2026-05-21	AVTXAvalo Therapeutics, Inc.A Award	Chief Legal Officer	AAward	+24.3K sh	—	—	27,934
2026-05-06	AVTXAvalo Therapeutics, Inc.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+62.5K sh	$13.43	+$839K	66,134
2026-05-06	AVTXAvalo Therapeutics, Inc.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+12.6K sh	$8.04	+$101K	78,697
2026-05-06	AVTXAvalo Therapeutics, Inc.S Sale	Chief Legal Officer	SSale	−37.4K sh	$18.91	−$707K	41,322
2026-05-06	AVTXAvalo Therapeutics, Inc.S Sale	Chief Legal Officer	SSale	−5,196 sh	$19.78	−$103K	36,126
2026-05-06	AVTXAvalo Therapeutics, Inc.S Sale	Chief Legal Officer	SSale	−22.8K sh	$21.22	−$485K	13,287
2026-05-06	AVTXAvalo Therapeutics, Inc.S Sale	Chief Legal Officer	SSale	−9,253 sh	$22.70	−$210K	4,034
2026-05-06	AVTXAvalo Therapeutics, Inc.S Sale	Chief Legal Officer	SSale	−400 sh	$23.71	−$9,484	3,634
2026-05-06	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−62.5K sh	—	—	87,500
2026-05-06	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−12.6K sh	—	—	87,437
2026-02-26	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+80K sh	—	—	80,000
2025-12-10	AVTXAvalo Therapeutics, Inc.F Tax Payment	Chief Legal Officer	FTax Payment	−1,016 sh	$4.10	−$4,165.6	3,634
2025-01-28	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+100K sh	—	—	100,000
2024-06-24	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+150K sh	—	—	150,000
2017-07-03	Zyla Life SciencesS Sale	SVP, GC & Chief Compliance Off	SSale	−806 sh	$2.35	−$1,894.1	29,514
2017-06-08	Zyla Life SciencesStock Option (Right to Buy)A Award	SVP, GC & Chief Compliance Off	AAward	+50K sh	—	—	50,000
2017-04-03	Zyla Life SciencesS Sale	SVP, GC & Chief Compliance Off	SSale	−806 sh	$5.05	−$4,070.3	28,820
2017-01-03	Zyla Life SciencesS Sale	SVP, GC & Chief Compliance Off	SSale	−806 sh	$7.75	−$6,246.5	29,626
2016-12-06	Zyla Life SciencesStock Option (Right to Buy)A Award	SVP, GC & Chief Compliance Off	AAward	+50K sh	—	—	50,000
2016-10-03	Zyla Life SciencesS Sale	SVP, GC & Chief Compliance Off	SSale	−806 sh	$7.56	−$6,093.36	30,432

Recent filings

Accepted (ET)
Jun 124
VARKI PAUL0001677896-26-000008
SEC(opens sec.gov)
May 264
VARKI PAUL0001677896-26-000006
SEC(opens sec.gov)
May 74
VARKI PAUL0001677896-26-000004
SEC(opens sec.gov)
Mar 24
VARKI PAUL0001677896-26-000002
SEC(opens sec.gov)
Dec 124
VARKI PAUL0001470831-25-000410
SEC(opens sec.gov)
Jan 304
VARKI PAUL0001578563-25-000029
SEC(opens sec.gov)
Jun 254
VARKI PAUL0001578563-24-000320
SEC(opens sec.gov)
Jul 64
Egalet Corp0001179110-17-010176
SEC(opens sec.gov)
Jun 124
Egalet Corp0001179110-17-008928
SEC(opens sec.gov)
Apr 44
Egalet Corp0001179110-17-005584
SEC(opens sec.gov)
Jan 44
Egalet Corp0001179110-17-000254
SEC(opens sec.gov)
Dec 84
Egalet Corp0001179110-16-032595
SEC(opens sec.gov)

Companies

Address

C/O AVALO THERAPEUTICS, INC. 1500 LIBERTY RIDGE DRIVE, SUITE 321

WAYNE, PA, 19087